A team of scientists at UCLA, United States, has shown it’s possible to reprogram haematopoietic stem cells to generate a regular supply of cancer-killing T cells. This novel approach, tested in a first-of-its-kind clinical trial the results of which were published in...

The first in-human trial of a stem cell therapy to treat hearing loss is due to begin later this year in the UK, after receiving MHRA approval. The trial will test whether the treatment is safe, as well as evaluate its effects on auditory function.[1] What is hearing...

The liver is a remarkably resilient organ - the only organ in the body capable of regenerating itself when damaged.[1] Damage to the liver does, however, build up over time, eventually leading first to chronic (long-term) liver disease and then, inevitably, to liver...